Fate Therapeutics (FATE) USD0.001

Sell:$1.27Buy:$1.35$0.07 (5.19%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$1.27
Buy:$1.35
Change:$0.07 (5.19%)
Market closed | Prices delayed by at least 15 minutes
Sell:$1.27
Buy:$1.35
Change:$0.07 (5.19%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 January 2025
Bahram (Bob) ValamehrChief Level Officer
Sell
Tax related
8,705$1.54$13,405.70349,364
10 January 2025
Cindy Robinson TahlCompany Secretary
Sell
Tax related
5,654$1.55$8,763.70336,707
10 January 2025
Jerome Charles BressiSenior Vice President
Sell
Tax related
5,980$1.55$9,269.00270,203
20 December 2024
REDMILE GROUP LLCVenture Capital
Buy
Regular purchase transaction
397,964$1.68$668,579.5212,884,277
20 December 2024
REDMILE GROUP LLCVenture Capital
Sell
Regular sell transaction (market)
341,633$1.68$573,943.4412,486,313
6 August 2024
Yuan XuIndependent Director
Sell
Regular sell transaction (market)
633$4.23$2,677.598,669

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
20 December 2024
REDMILE GROUP LLCVenture Capital
Buy
Regular purchase transaction
397,964$1.68$668,579.5212,884,277
20 December 2024
REDMILE GROUP LLCVenture Capital
Sell
Regular sell transaction (market)
341,633$1.68$573,943.4412,486,313
10 January 2025
Bahram (Bob) ValamehrChief Level Officer
Sell
Tax related
8,705$1.54$13,405.70349,364
10 January 2025
Jerome Charles BressiSenior Vice President
Sell
Tax related
5,980$1.55$9,269.00270,203
10 January 2025
Cindy Robinson TahlCompany Secretary
Sell
Tax related
5,654$1.55$8,763.70336,707

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.